| Absorption | 
      | Blood-Brain Barrier | BBB+ | 0.9469 | 
      | Human Intestinal Absorption | HIA+ | 0.9893 | 
      | Caco-2 Permeability | Caco2- | 0.5303 | 
      | P-glycoprotein Substrate | Substrate | 0.8460 | 
      | P-glycoprotein Inhibitor | Inhibitor | 0.8809 | 
                                                     | Inhibitor | 0.6834 | 
      | Renal Organic Cation Transporter | Inhibitor | 0.5248 | 
        
            | Distribution | 
        
      | Subcellular localization | Mitochondria | 0.7183 | 
        
          | Metabolism | 
        
      | CYP450 2C9 Substrate | Non-substrate | 0.6788 | 
      | CYP450 2D6 Substrate | Substrate | 0.7697 | 
      | CYP450 3A4 Substrate | Non-substrate | 0.6440 | 
      | CYP450 1A2 Inhibitor | Inhibitor | 0.8354 | 
      | CYP450 2C9 Inhibitor | Non-inhibitor | 0.9186 | 
        | CYP450 2D6 Inhibitor | Inhibitor | 0.8979 | 
      | CYP450 2C19 Inhibitor | Non-inhibitor | 0.8746 | 
      | CYP450 3A4 Inhibitor | Non-inhibitor | 0.7426 | 
      | CYP Inhibitory Promiscuity | High CYP Inhibitory Promiscuity | 0.5000 | 
        
          | Excretion | 
        
        
          | Toxicity | 
        
      | Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.8509 | 
                                                                    | Inhibitor | 0.7117 | 
      | AMES Toxicity | Non AMES toxic | 0.8170 | 
      | Carcinogens | Non-carcinogens | 0.8910 | 
      | Fish Toxicity | High FHMT | 0.5000 | 
      | Tetrahymena Pyriformis Toxicity | High TPT | 0.8217 | 
      | Honey Bee Toxicity | Low HBT | 0.7969 | 
      | Biodegradation | Not ready biodegradable | 0.9893 | 
      | Acute Oral Toxicity | II | 0.6084 | 
      | Carcinogenicity (Three-class) | Non-required | 0.7029 |